{"id":183900,"date":"2022-09-19T08:23:36","date_gmt":"2022-09-19T08:23:36","guid":{"rendered":"https:\/\/www.healthbenefitstimes.com\/glossary\/?p=183900"},"modified":"2022-09-19T08:25:39","modified_gmt":"2022-09-19T08:25:39","slug":"metyrapone-test","status":"publish","type":"post","link":"https:\/\/www.healthbenefitstimes.com\/glossary\/metyrapone-test\/","title":{"rendered":"Metyrapone test"},"content":{"rendered":"

One of several diagnostic tests to assess the integrity of the pituitary-adrenal axis, esp. used in the diagnosis of adrenocorticotropic hormone (ACTH) deficiencies and Cushing\u2019s disease. The drug metyrapone, which inhibits the secretion of cortisol by the adrenal glands, may be given at timed intervals during the day, or as a single nighttime dose. Depending on the method of administration, plasma levels of cortisol, 11-deoxycortisol, or ACTH, or urinary levels of 17-hydroxysteroid, are evaluated to assess the patient\u2019s response.<\/p>\n

\n

 <\/p>\n","protected":false},"excerpt":{"rendered":"

One of several diagnostic tests to assess the integrity of the pituitary-adrenal axis, esp. used in the diagnosis of adrenocorticotropic hormone (ACTH) deficiencies and Cushing\u2019s disease. The drug metyrapone, which inhibits the secretion of cortisol by the adrenal glands, may be given at timed intervals during the day, or as a single nighttime dose. Depending […]<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":["post-183900","post","type-post","status-publish","format-standard","hentry","category-m"],"yoast_head":"\nMetyrapone test - Definition of Metyrapone test<\/title>\n<meta name=\"description\" content=\"One of several diagnostic tests to assess the integrity of the pituitary-adrenal axis, esp. used in the diagnosis of adrenocorticotropic hormone (ACTH) deficiencies and Cushing\u2019s disease. The drug metyrapone, which inhibits the secretion of cortisol by the adrenal glands, may be given at timed intervals during the day, or as a single nighttime dose. Depending on the method of administration, plasma levels of cortisol, 11-deoxycortisol, or ACTH, or urinary levels of 17-hydroxysteroid, are evaluated to assess the patient\u2019s response.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.healthbenefitstimes.com\/glossary\/metyrapone-test\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Metyrapone test - Definition of Metyrapone test\" \/>\n<meta property=\"og:description\" content=\"One of several diagnostic tests to assess the integrity of the pituitary-adrenal axis, esp. used in the diagnosis of adrenocorticotropic hormone (ACTH) deficiencies and Cushing\u2019s disease. The drug metyrapone, which inhibits the secretion of cortisol by the adrenal glands, may be given at timed intervals during the day, or as a single nighttime dose. Depending on the method of administration, plasma levels of cortisol, 11-deoxycortisol, or ACTH, or urinary levels of 17-hydroxysteroid, are evaluated to assess the patient\u2019s response.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.healthbenefitstimes.com\/glossary\/metyrapone-test\/\" \/>\n<meta property=\"og:site_name\" content=\"Glossary\" \/>\n<meta property=\"article:published_time\" content=\"2022-09-19T08:23:36+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2022-09-19T08:25:39+00:00\" \/>\n<meta name=\"author\" content=\"Glossary\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Glossary\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/metyrapone-test\/\",\"url\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/metyrapone-test\/\",\"name\":\"Metyrapone test - Definition of Metyrapone test\",\"isPartOf\":{\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/#website\"},\"datePublished\":\"2022-09-19T08:23:36+00:00\",\"dateModified\":\"2022-09-19T08:25:39+00:00\",\"author\":{\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/#\/schema\/person\/ccfef987a4882e6356ae6d77d33e74c5\"},\"description\":\"One of several diagnostic tests to assess the integrity of the pituitary-adrenal axis, esp. used in the diagnosis of adrenocorticotropic hormone (ACTH) deficiencies and Cushing\u2019s disease. The drug metyrapone, which inhibits the secretion of cortisol by the adrenal glands, may be given at timed intervals during the day, or as a single nighttime dose. Depending on the method of administration, plasma levels of cortisol, 11-deoxycortisol, or ACTH, or urinary levels of 17-hydroxysteroid, are evaluated to assess the patient\u2019s response.\",\"breadcrumb\":{\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/metyrapone-test\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.healthbenefitstimes.com\/glossary\/metyrapone-test\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/metyrapone-test\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Metyrapone test\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/#website\",\"url\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/\",\"name\":\"Glossary\",\"description\":\"Difinitions\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/#\/schema\/person\/ccfef987a4882e6356ae6d77d33e74c5\",\"name\":\"Glossary\",\"url\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/author\/adminglossary\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Metyrapone test - Definition of Metyrapone test","description":"One of several diagnostic tests to assess the integrity of the pituitary-adrenal axis, esp. used in the diagnosis of adrenocorticotropic hormone (ACTH) deficiencies and Cushing\u2019s disease. The drug metyrapone, which inhibits the secretion of cortisol by the adrenal glands, may be given at timed intervals during the day, or as a single nighttime dose. Depending on the method of administration, plasma levels of cortisol, 11-deoxycortisol, or ACTH, or urinary levels of 17-hydroxysteroid, are evaluated to assess the patient\u2019s response.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.healthbenefitstimes.com\/glossary\/metyrapone-test\/","og_locale":"en_US","og_type":"article","og_title":"Metyrapone test - Definition of Metyrapone test","og_description":"One of several diagnostic tests to assess the integrity of the pituitary-adrenal axis, esp. used in the diagnosis of adrenocorticotropic hormone (ACTH) deficiencies and Cushing\u2019s disease. The drug metyrapone, which inhibits the secretion of cortisol by the adrenal glands, may be given at timed intervals during the day, or as a single nighttime dose. Depending on the method of administration, plasma levels of cortisol, 11-deoxycortisol, or ACTH, or urinary levels of 17-hydroxysteroid, are evaluated to assess the patient\u2019s response.","og_url":"https:\/\/www.healthbenefitstimes.com\/glossary\/metyrapone-test\/","og_site_name":"Glossary","article_published_time":"2022-09-19T08:23:36+00:00","article_modified_time":"2022-09-19T08:25:39+00:00","author":"Glossary","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Glossary"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/metyrapone-test\/","url":"https:\/\/www.healthbenefitstimes.com\/glossary\/metyrapone-test\/","name":"Metyrapone test - Definition of Metyrapone test","isPartOf":{"@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/#website"},"datePublished":"2022-09-19T08:23:36+00:00","dateModified":"2022-09-19T08:25:39+00:00","author":{"@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/#\/schema\/person\/ccfef987a4882e6356ae6d77d33e74c5"},"description":"One of several diagnostic tests to assess the integrity of the pituitary-adrenal axis, esp. used in the diagnosis of adrenocorticotropic hormone (ACTH) deficiencies and Cushing\u2019s disease. The drug metyrapone, which inhibits the secretion of cortisol by the adrenal glands, may be given at timed intervals during the day, or as a single nighttime dose. Depending on the method of administration, plasma levels of cortisol, 11-deoxycortisol, or ACTH, or urinary levels of 17-hydroxysteroid, are evaluated to assess the patient\u2019s response.","breadcrumb":{"@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/metyrapone-test\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.healthbenefitstimes.com\/glossary\/metyrapone-test\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/metyrapone-test\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.healthbenefitstimes.com\/glossary\/"},{"@type":"ListItem","position":2,"name":"Metyrapone test"}]},{"@type":"WebSite","@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/#website","url":"https:\/\/www.healthbenefitstimes.com\/glossary\/","name":"Glossary","description":"Difinitions","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.healthbenefitstimes.com\/glossary\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/#\/schema\/person\/ccfef987a4882e6356ae6d77d33e74c5","name":"Glossary","url":"https:\/\/www.healthbenefitstimes.com\/glossary\/author\/adminglossary\/"}]}},"_links":{"self":[{"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/posts\/183900","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/comments?post=183900"}],"version-history":[{"count":1,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/posts\/183900\/revisions"}],"predecessor-version":[{"id":183901,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/posts\/183900\/revisions\/183901"}],"wp:attachment":[{"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/media?parent=183900"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/categories?post=183900"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/tags?post=183900"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}